RLS Drugs: What Works, What to Avoid & Costs in 2026

April 22, 2026
Neurological Health
Featured Post

If your legs won't settle down at night and you're staring at the ceiling wondering what the deal is — you've probably landed on restless legs syndrome. Maybe your doctor already said the words. Maybe you've tried a medication that worked for a while, then stopped. Either way, the prescribing landscape for RLS looks different in 2026 than it did even a few years ago, and that matters for what you get handed at the pharmacy counter.

Here's the short version: the drugs that used to be first-line for RLS are now second-line — because over time they often make symptoms worse. The drugs that used to be secondary are now the preferred starting point. And the cost spread between these options is enormous, especially if you're paying cash.

At a glance

  • Current guidelines name alpha-2-delta ligands (gabapentin, gabapentin enacarbil, pregabalin) and iron as first-line treatments for moderate-to-severe RLS
  • Dopamine agonists — ropinirole, pramipexole, and the rotigotine patch (Neupro) — are now second-line because they can cause augmentation, a worsening of symptoms with continued use
  • Cash-pay prices vary dramatically: generic gabapentin runs a few dollars a month at US pharmacies, while brand-name Horizant can exceed $700 for a 30-day supply without coverage
  • Checking ferritin levels is a cheap, often-overlooked first step — iron deficiency drives a large share of RLS cases
  • Some common over-the-counter drugs (antihistamines, certain nausea meds, some antidepressants) can trigger or worsen RLS, so a medication review is worth doing before adding anything new

How RLS prescribing changed in 2026

For years, if you showed up with moderate-to-severe RLS, you walked out with a dopamine agonist — ropinirole (Requip is the generic now), pramipexole (Mirapex), or the rotigotine patch. They worked. Then, often, they didn't — or they did, but symptoms started creeping earlier in the day, spreading to the arms, getting more intense. That's augmentation, and it happens to an estimated 5–10% of patients on dopamine agonists every year they stay on treatment.

Updated American Academy of Sleep Medicine and movement disorder society guidelines (refreshed in late 2024) pushed the alpha-2-delta ligands — gabapentin, gabapentin enacarbil (Horizant), and pregabalin — to the front of the line. These drugs don't cause augmentation. They come with their own tradeoffs, but for most new RLS patients, they're now where treatment starts.

That's the backdrop. The actual drugs and what they cost are below.

First-line RLS drugs: alpha-2-delta ligands

These work on calcium channels in the brain to dampen the abnormal nerve signaling that drives RLS. They're also used for neuropathic pain and seizures, which is why they often show up cheap as generics.

Gabapentin

Gabapentin is the workhorse. It's generic, widely stocked, and inexpensive. For RLS, doses usually land in the 300–1,800 mg range taken in the evening, titrated slowly from a starting dose of 100–300 mg to limit side effects. Sleepiness is the big one — which can actually be useful at bedtime, less so the next morning. Dizziness, unsteadiness, and mild weight gain can happen. Older adults need dose adjustments because the kidneys clear it.

Cash price at major US retail chains in 2026: roughly $4–$15 for a 30-day supply of 300 mg capsules on discount programs. It's one of the few medications where cash-pay is often cheaper than going through insurance.

Gabapentin enacarbil (Horizant)

Horizant is a prodrug of gabapentin — it converts to gabapentin in the body but absorbs more predictably, which was the selling point for FDA approval specifically for RLS. The standard dose is 600 mg once daily, taken around 5 p.m. with food.

Here's the catch: Horizant has no generic. Cash prices run in the range of $700–$900 for a 30-count supply of 600 mg tablets at US retail pharmacies. For a drug that delivers what's essentially gabapentin to your system, that's a substantial price jump. Many patients start on plain gabapentin and only move to Horizant if absorption has been unpredictable.

Pregabalin (Lyrica)

Pregabalin works similarly to gabapentin but with more predictable absorption. It's now generic, which brought the price down considerably from the brand-name Lyrica era. Doses for RLS typically sit at 150–450 mg daily, split or taken in the evening.

Cash price: generic pregabalin runs about $10–$30 for a 30-day supply of 75 mg capsules at major chains with discount programs. Brand-name Lyrica is still around — and still expensive, often $500+ for the same supply — though there's no clinical reason to pick it over the generic.

Savings tip: If you're prescribed Lyrica or Horizant without being told about cheaper options, ask your prescriber whether plain gabapentin or generic pregabalin would work first. Many prescribers default to the brand they remember seeing advertised, not the cheapest effective option. On the cash-pay side, generic gabapentin can cost less in a month than one brand-name tablet.

Second-line RLS drugs: dopamine agonists

These were standard for years. They still work — and still have a place, particularly for short-term use or for patients who can't tolerate alpha-2-delta ligands. But augmentation makes them a harder sell as first-line.

Ropinirole

Ropinirole (formerly brand-name Requip) is a generic dopamine agonist dosed at 0.25 mg up to 4 mg in the evening for RLS, with the lowest effective dose being the goal. It works quickly — often within a few days — which is part of why it became popular in the first place.

Side effects include nausea, dizziness, daytime sleepiness, and, more rarely, impulse control problems (gambling, shopping, eating compulsions) that can be severe enough to require stopping the drug. Augmentation risk rises with dose and duration of use.

Cash price: generic ropinirole is widely available and runs approximately $10–$40 per month at US retail chains depending on dose and pharmacy.

Pramipexole

Pramipexole (brand name Mirapex) is similar in profile to ropinirole, with doses for RLS generally ranging from 0.125 mg to 0.75 mg once daily in the evening. The side effect profile is comparable — nausea, sleepiness, augmentation risk — though some patients tolerate one better than the other.

Cash price: generic pramipexole sits in a similar range, roughly $10–$35 per month at major chains.

Rotigotine patch (Neupro)

The rotigotine patch (Neupro) delivers the drug through the skin over 24 hours, which gives more stable blood levels than an oral pill. For RLS, doses are 1 mg/24 hours up to 3 mg/24 hours.

The patch has its own quirks: skin reactions at the application site are common, and you have to rotate locations. Augmentation can still happen. It's also expensive. There's no generic yet in the US — cash prices for a 30-day supply of Neupro patches can exceed $1,000 depending on dose and pharmacy.

The drug that isn't a drug: iron

Iron deficiency — often without anemia on the standard blood test — is a major driver of RLS. Current guidelines recommend checking a ferritin level (a blood test that reflects stored iron) in anyone with RLS. If ferritin is below 75 ng/mL, iron supplementation is often appropriate, either oral or intravenous.

This matters for two reasons. First, correcting iron sometimes clears RLS without any other medication. Second, it's cheap — a bottle of oral ferrous sulfate costs a few dollars at any US pharmacy. IV iron is more expensive but typically covered by medical insurance as a diagnostic-driven intervention. Either way, this step shouldn't be skipped before jumping to long-term RLS medication.

One practical note: oral iron can cause constipation and stomach upset. Taking it with vitamin C helps absorption; taking it with calcium (including dairy) blunts it.

Other RLS drugs worth knowing about

Benzodiazepines

Clonazepam is the one most commonly used for RLS, prescribed occasionally at bedtime for patients whose main issue is sleep disruption. It's cheap as a generic and helps with sleep, but it doesn't treat the underlying RLS — and it comes with the usual benzodiazepine concerns: tolerance, dependence, interactions with opioids and alcohol, and risks in older adults. Most specialists reserve benzodiazepines for intermittent use or as an add-on.

Low-dose opioids

For severe, refractory RLS — meaning symptoms don't respond to standard treatments — low-dose oxycodone, codeine, or methadone is sometimes prescribed. This is specialist territory, typically managed through a sleep or movement disorder clinic, and carries the obvious risks. It's not a first call, but it's in the toolbox for patients who've exhausted the options above.

Levodopa/carbidopa (Sinemet)

Levodopa/carbidopa was once used regularly for RLS. It's effective but has a very high rate of augmentation — higher than any other dopamine-based treatment — so current guidelines largely limit it to intermittent use for occasional, situational RLS (think a long flight or a night at the movies) rather than daily treatment.

RLS drugs to avoid — and drugs that can trigger symptoms

Some widely used medications can cause or worsen restless legs. Worth reviewing your current list with your prescriber before adding an RLS drug:

  • Sedating antihistamines — diphenhydramine (the active ingredient in most PM sleep aids, including Benadryl and ZzzQuil), doxylamine, hydroxyzine. These commonly trigger or worsen RLS.
  • Certain antidepressants — especially SSRIs, SNRIs, and tricyclics. Bupropion and trazodone tend to be better tolerated if an antidepressant is needed alongside RLS treatment.
  • Antipsychotics and some nausea meds — drugs that block dopamine, including prochlorperazine, promethazine, and metoclopramide, can sharply worsen RLS.
  • Antihistamine decongestant combos — a lot of cold and sleep products contain diphenhydramine under other brand names. Check the label.

If you take one of these for something important, switching isn't always possible. But knowing the interaction is useful when you and your doctor are deciding what to try next.

What RLS drugs actually cost without insurance

Pricing varies by dose, pharmacy, and geography. These are rough 2026 cash-pay ranges at major US retail chains using standard discount programs:

Medication Typical monthly cash price (US) Generic available?
Gabapentin (generic) $4–$15 Yes
Pregabalin (generic) $10–$30 Yes
Lyrica (brand) $500+ N/A — use generic
Horizant (gabapentin enacarbil) $700–$900 No
Ropinirole (generic) $10–$40 Yes
Pramipexole (generic) $10–$35 Yes
Neupro (rotigotine patch) $1,000+ No
Clonazepam (generic) $5–$20 Yes
Levodopa/carbidopa (generic) $15–$40 Yes

For the generics, the price spread between insurance copay and cash-pay is often small — sometimes cash with a discount card beats the copay. For the brand-name holdouts (Horizant, Neupro), cash-pay through a network like CanAmerica Plus can bring the price down significantly compared to retail US pharmacy pricing, especially for long-term users.

The bottom line

In 2026, if you're newly diagnosed with moderate-to-severe RLS, expect to start with iron evaluation and — if medication is needed — gabapentin or pregabalin, not a dopamine agonist. If you're already on ropinirole or pramipexole and symptoms are drifting earlier in the day or getting more intense, that's a conversation with your prescriber about possible augmentation. Don't change the dose on your own — dopamine agonists need careful tapering.

And check the cash prices. The gap between generic gabapentin at $10 and brand-name Horizant at $800 is about as wide as it gets in prescription pricing, for drugs doing very similar things.

Frequently asked questions

What is the first-line drug for restless leg syndrome now?

Updated 2024 guidelines name the alpha-2-delta ligands — gabapentin, gabapentin enacarbil, and pregabalin — along with iron supplementation when ferritin is low. Dopamine agonists like ropinirole and pramipexole are now considered second-line because of the risk of augmentation with long-term use.

Is there a new cure for restless leg syndrome?

No — there's no cure, and anything claiming to be one should be viewed skeptically. What has changed is the treatment approach: better recognition that iron deficiency drives many cases, a move away from dopamine agonists as first-line, and renewed interest in alpha-2-delta ligands. These are management strategies, not cures.

Can you stop restless legs immediately with a drug?

Short answer: no medication works that fast. Most RLS drugs take days to weeks to titrate to an effective dose. For a one-off bad night, walking around, stretching, a hot or cold bath, or a caffeine and alcohol check can help more than trying to force a drug to work immediately. For ongoing relief, consistent use of a prescribed regimen is what works.

Which is better, gabapentin or ropinirole?

For most newly diagnosed patients, gabapentin is now preferred because it doesn't cause augmentation. Ropinirole works faster initially, but the long-term risk of symptoms worsening tips current guidelines toward gabapentin as the first trial. That said, some patients tolerate ropinirole better or get faster relief, so the "better" drug is the one that works for you without causing problems over time.

Are there over-the-counter medications for RLS?

Not really. The OTC options that people try — diphenhydramine, melatonin, magnesium supplements — either don't help or can make RLS worse. The exception is iron supplementation when deficiency is confirmed, and that should be guided by a ferritin test, not self-started.


This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment. Pricing information is current as of the publication date but may change. Verify pricing directly before making purchasing decisions.